Norwood practice data on T2D remission March 2015–April 2021
| Data collected to: | Mean duration of low-carbohydrate approach | No of T2D cases in remission HbA1c<48* | No of choosing the approach | Remission rate for people who choose the low-carbohydrate approach | No of patients with T2D on the diabetic register | Overall remission rate for practice |
| March 2017 | 13 months | 15 | 48 | 31% | 416 | 4% |
| May 2018 | 20 months | 41 | 106 | 39% | 454 | 9% |
| January 2019 | 22 months | 59 | 123 | 48% | 469 | 13% |
| March 2020 | 30 months | 68 | 143 | 48% | 485 | 14% |
| April 2021 | 33 months | 94 | 186 | 51% | 473 | 20% |
*T2D remission defined as: previous diagnosis of T2D by WHO criteria and HbA1c <6.5% (<48 mmol/mol) without antidiabetes medication. As per McCombie et al.39 in mmol/mol.
HbA1c, Glycated haemoglobin; T2D, type 2 diabetes .